Clinical usage of ischemic tolerance-where are its limits? DOI Creative Commons
Rastislav Burda,

Róbert Křemen,

Miroslava Némethová

et al.

Asian Journal of Surgery, Journal Year: 2024, Volume and Issue: 47(11), P. 4674 - 4680

Published: May 31, 2024

Ischemic tolerance is a robust internal defense mechanism of all living organisms. The effectiveness this has been repeatedly demonstrated in experiments, but comprehensive review the clinical applicability phenomenon practice not yet published. results sound ambiguous and unconvincing comparison with experimental studies. Also, many localities, effect ischemic was clinically proven. For reasons mentioned, authors analyze possible causes mentioned discrepancies provide insight into relevant use for different groups patients.

Language: Английский

Role of orphan G-protein coupled receptors in tissue ischemia: A comprehensive review DOI

Alireza Keifi Bajestani,

Mohaddeseh Sadat Alavi, Leila Etemad

et al.

European Journal of Pharmacology, Journal Year: 2024, Volume and Issue: 978, P. 176762 - 176762

Published: June 19, 2024

Language: Английский

Citations

4

Inhibition of matrix metalloproteinases to reduce blood brain barrier disruption and haemorrhagic transformation in ischaemic stroke: go broad or go narrow? DOI

Hala Kawa,

Zubair Ahmed, Arshad Majid

et al.

Neuropharmacology, Journal Year: 2024, Volume and Issue: unknown, P. 110192 - 110192

Published: Oct. 1, 2024

Language: Английский

Citations

4

Anwulignan Alleviates IRI by the Activation of Nrf2/HO-1 Signaling Pathway and Inhibiting NLRP3-Caspase-1-GSDMD-Mediated Pyroptosis in Rats DOI
Xin Wang, Shuhong Wu, Yuxin Jiang

et al.

Tissue and Cell, Journal Year: 2025, Volume and Issue: 93, P. 102775 - 102775

Published: Feb. 6, 2025

Language: Английский

Citations

0

Intermittent fasting induced cerebral ischemic tolerance altered gut microbiome and increased levels of short-chain fatty acids to a beneficial phenotype DOI
Bharath Chelluboina,

T.H. Cho,

Jin-Soo Park

et al.

Neurochemistry International, Journal Year: 2024, Volume and Issue: 178, P. 105795 - 105795

Published: June 20, 2024

Language: Английский

Citations

3

Effects of Trehalose Preconditioning on H9C2 Cell Viability and Autophagy Activation in a Model of Donation after Circulatory Death for Heart Transplantation DOI Creative Commons
Jingwen Gao, Yasushige Shingu, Satoru Wakasa

et al.

Current Issues in Molecular Biology, Journal Year: 2024, Volume and Issue: 46(4), P. 3353 - 3363

Published: April 12, 2024

Donation after circulatory death (DCD) is a promising strategy for alleviating donor shortage in heart transplantation. Trehalose, an autophagy inducer, has been shown to be cardioprotective ischemia-reperfusion (IR) model; however, its role IR injury DCD remains unknown. In the present study, we evaluated effects of trehalose on cardiomyocyte viability and activation model. model, cardiomyocytes (H9C2) were exposed 1 h warm ischemia, cold reperfusion. Trehalose was administered before ischemia (preconditioning), during or Cell measured using Counting Kit-8 treatment with trehalose. Autophagy by measuring flux inhibitor, chloroquine, microtubule-associated protein 1A/1B light chain 3 B (LC3)-II western blotting. ischemic period (trehalose preconditioning) increased cell viability. The protective preconditioning negated chloroquine treatment. Furthermore, flux. through which could prevention damage

Language: Английский

Citations

1

Early Detection of Pressure Ulcers: Considering Dynamic Phenomena and Temperature DOI

Nicolas Gillard,

P. Coignard,

J. Kerdraon

et al.

2021 International Conference on Computational Science and Computational Intelligence (CSCI), Journal Year: 2023, Volume and Issue: unknown, P. 1503 - 1506

Published: Dec. 13, 2023

Language: Английский

Citations

1

MECHANISMS OF VASOPROTECTION AND CARDIOPROTECTION IN HYPOXYTHERAPY OF ARTERIAL HYPERTENSION AND CORONARY ARTERY DISEASE DOI Creative Commons

Г. А. Игнатенко

Complex Issues of Cardiovascular Diseases, Journal Year: 2024, Volume and Issue: 13(1), P. 98 - 108

Published: March 29, 2024

Highlights The article presents a modern understanding of the main links functional circulatory regulation system and its response to exogenous hypoxia, as well describes data available on molecular mechanisms vasoprotection cardioprotection involved in hypoxytherapy patients with arterial hypertension coronary artery disease. Abstract Hypoxic conditioning has taken an important place range non-drug methods for stimulating adaptive potential healthy person cardiovascular diseases. There are many approaches use various however, there is no consensus essence sanogenetic that provide multi-level maintaining oxygen supply blood circulation. Adaptive reactions afferent, central efferent hypoxia described. results studies physiological systemic realized by respiratory vegetative plasticity using interval (intermittent) presented. In disease, facts chemoreflective stimulation modulation lung ventilation, autonomic nervous status, especially sympathetic activity peripheral vessels vagal activation cardiac have been established. vaso- cardioprotective properties based leveling oxidative stress, inflammation, angiogenesis, shift secretory endothelium towards vasodilating, antiproliferative, antithrombotic mediators. We present evidence role shear stress state glycocalyx, angiopoietin adrenomedulline vascular tone, cytoprotective cytoplasmic mitochondrial metabolic factors formation ischemic tolerance cardiomyocytes. issues relationship between (neuronal humoral) structural responses target cells providing adaptive/compensatory regulating circulation under influence require further research evaluation.

Language: Английский

Citations

0

Clinical usage of ischemic tolerance-where are its limits? DOI Creative Commons
Rastislav Burda,

Róbert Křemen,

Miroslava Némethová

et al.

Asian Journal of Surgery, Journal Year: 2024, Volume and Issue: 47(11), P. 4674 - 4680

Published: May 31, 2024

Ischemic tolerance is a robust internal defense mechanism of all living organisms. The effectiveness this has been repeatedly demonstrated in experiments, but comprehensive review the clinical applicability phenomenon practice not yet published. results sound ambiguous and unconvincing comparison with experimental studies. Also, many localities, effect ischemic was clinically proven. For reasons mentioned, authors analyze possible causes mentioned discrepancies provide insight into relevant use for different groups patients.

Language: Английский

Citations

0